SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-23-270503
Filing Date
2023-11-03
Accepted
2023-11-03 17:11:04
Documents
11
Period of Report
2023-11-03

Document Format Files

Seq Description Document Type Size
1 PREM14A d873327dprem14a.htm PREM14A 2143789
2 EX-FILING FEES d873327dexfilingfees.htm EX-FILING FEES 20806
3 GRAPHIC g873327dsp072.jpg GRAPHIC 348550
4 GRAPHIC g873327dsp073.jpg GRAPHIC 370049
5 GRAPHIC g873327dsp074.jpg GRAPHIC 399303
6 GRAPHIC g873327dsp075.jpg GRAPHIC 438083
7 GRAPHIC g873327g02m95.jpg GRAPHIC 75026
8 GRAPHIC g873327g06i56.jpg GRAPHIC 23376
9 GRAPHIC g873327g18p98.jpg GRAPHIC 48529
10 GRAPHIC g873327g55d76.jpg GRAPHIC 15915
11 GRAPHIC g873327g99f18.jpg GRAPHIC 15716
  Complete submission text file 0001193125-23-270503.txt   4556136
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-38722 | Film No.: 231377308
SIC: 2836 Biological Products, (No Diagnostic Substances)